Does Pimecrolimus Cream Enhance the Effect of Excimer Laser on Eyelid Vitiligo?
Journal of Lasers in Medical Sciences,
Vol. 2 No. 1 (2011),
26 April 2011
,
Page 26-29
Abstract
INTRODUCTION: Vitiligo is a cutaneous disorder of pigmentation, for which, there are some proven modalities of treatment. In this study, we evaluated the efficacy of the addition of topical pimecrolimus to 308nm Excimer laser in reducing treatment duration and improving the response rate of eyelid vitiligo, compared with 308nm Excimer laser monotherapy.METHODS: Fifty two symmetrically localized lesions of eyelid vitiligo in 26 patients were observed. Each of vitiliginous patches was treated with 308nm Excimer laser twice a week for a total of 30 sessions. Topical pimecrolimus 1% cream was applied to the patches of right eyelid(group A lesions) and eucerine cream as a placebo to the left side patches(group B lesions)twice daily, throughout the study. Photographs were taken at baseline, 6 and 15 weeks after starting the treatment.
RESULTS: Twenty two patients (44 lesions) completed the study. Repigmentation was appeared in all (100%) of groups A and B lesions. A 75% or more repigmentation was achieved in 17(78%) of group A versus 14 (64%) of group B lesions. The average number of sessions needed for the appearance of repigmentation was 8 for group A lesions and 12 for group. The repigmentaion of 50% or more in patients with disease duration of 2 years or less and those with more than 2 years duration ere 100% and 59.2%, respectively.
CONCLUSION: Repigmentation rate obtained by the combination therapy of eyelid vitiligo with 308nm Excimer laser and topical Pimecrolimus 1%cream is significantly higher, and obtained in fewer sessions in comparison with 308nm Excimer laser and placebo combination therapy.
- Pimecrolimus
- Lasers
- Excimer
- Vitiligo
- Eyelid
- Clinical Trial
- Laser Therapy
How to Cite
References
Njoo MD, Westerhof W. Vitiligo. Ned Tijdschr Geneeskd.1997 Apr 19;141(16):759-64.
Passeron T.,Ortonne JP. The 308-nm excimer laser in dermatology.Presse Med.2005 Feb 26;34(4):301-9.
Boone B.,Ongenae K. Topical pimecrolimus in the treatment of vitiligo.European Journal of Dermatology.2007 January-February ;17(1):55-61.
Ruzicka Th, Assmann T. Tacrolimus. The drug for the turn of the Millennium. Arch Dermatol. 1999;135:574-80.
Yang Hui-Lan, Huang Xiao-Yan, Combination of 308- nm excimer laser with topical Pimecrolimus for the treatment of childhood vitiligo. Pediatr Dermatol, 2009 May-june;26 (3):354-6.
Grimes PE. Diseases of hypopigmentation. In: Sams WM,Lynch PJ, eds. Principles and Practice of Dermatology,2nd ed. New York: Churchil-Livingstone; 1996. 873-85.
Hossani-Madani AR, Halder RM. Topical treatment and combination approaches for vitiligo: new insights,new developments. G Ital Dermatol Venereol. 2010 Feb;145(1):57-78.
Njoo MD ,Spuls PI, Bos JD. Nonsurgical Repigmentation therapies in vitiligo. Arch Dermatol 1998;134:1532-40.
Kawalek AZ, Spencer JM, Phelps RG. Combined Excimer Laser and topical Tacrolimus for the treatment of vitiligo:A pilot study. Dermatol Surg. 2004;30:130-5.
Hofer A, Hassan AS, Legat FJ, Kerl H, Wolf P. The efficacy of excimer laser (308-nm) for vitiligo at different body sites. J Eur Acad Dermatol Venereol.2006 May;20(5):558-64.
Passeron T, Ostovari N, Zakaria W, Fontas E, Larrouy JC, Lacour JP, Ortonne JP. Topical Tacrolimus and 308-nm excimer laser, a synergistic combination combination for the treatment of vitiligo. Arch Dermatol. 2004 Sep;140(9):1065-9.
Zhang XY, He YL, Dong J, Xu JZ, Wang J. Clinical efficacy of a 308-nm excimer laser in the treatment of vitiligo. Photodermatol Photoimmunol Photomed. 2010 june;26(3):138-42.
- Abstract Viewed: 446 times
- PDF Downloaded: 483 times